Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trial

Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from the Extension of the Cohort Study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE)

(2021) Alejandro Arana et al.   Clinical Epidemiology

Treatment of early‐stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Study (PROCLIPI study)

(2020) P. Quaglino et al.   BRITISH JOURNAL OF DERMATOLOGY

The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T‐cell lymphoma

(2020) Julia J. Scarisbrick et al.   BRITISH JOURNAL OF HAEMATOLOGY

The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas

(2019) Rein Willemze et al.   BLOOD

Skin Directed Therapy in Cutaneous T-Cell Lymphoma

(2019) Erica S. Tarabadkar et al.   Frontiers in Oncology

Frequent and persistent PLCG1 mutations in Sézary cells directly enhance PLCγ1 activity and stimulate NFκB, AP-1 and NFAT signaling. Short title: Gain-of-function PLCG1 mutations in Sézary Syndrome

(2019) Varsha M. Patel et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation – JOELLE study)

(2018) Jordi Castellsague et al.   Clinical Epidemiology

Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides

(2018) Armando N. Bastidas Torres et al.   GENES CHROMOSOMES & CANCER

Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides

(2015) L. Y. McGirt et al.   BLOOD

Genomic landscape of cutaneous T cell lymphoma

(2015) Jaehyuk Choi et al.   NATURE GENETICS

The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome

(2015) Ana Carolina da Silva Almeida et al.   NATURE GENETICS

Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes

(2015) Linghua Wang et al.   NATURE GENETICS

PLCG1 mutations in cutaneous T-cell lymphomas

(2014) José P. Vaqué et al.   BLOOD

Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines

(2014) Ivan V Litvinov et al.   CELL CYCLE

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)

(2014) Sarah I. Jawed et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)

(2014) Sarah I. Jawed et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma

(2013) Katharina Kopp et al.   CELL CYCLE

VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing

(2012) D. C. Koboldt et al.   GENOME RESEARCH

Topical Chemotherapy in Cutaneous T-cell Lymphoma

(2012) Stuart R. Lessin et al.   JAMA Dermatology

Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

(2011) Elise A. Olsen et al.   JOURNAL OF CLINICAL ONCOLOGY

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

(2010) K. Wang et al.   NUCLEIC ACIDS RESEARCH